ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.9% | 40 | -33.3% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | -60.0% | 60 | -33.3% | 0.00% | -50.0% |
| Q2 2022 | $5,000 | -28.6% | 90 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $7,000 | -12.5% | 90 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | 0.0% | 90 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | -38.5% | 90 | -35.7% | 0.00% | -40.0% |
| Q2 2021 | $13,000 | -18.8% | 140 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $16,000 | -15.8% | 140 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $19,000 | +58.3% | 140 | 0.0% | 0.01% | +60.0% |
| Q3 2020 | $12,000 | +200.0% | 140 | +40.0% | 0.01% | +150.0% |
| Q4 2019 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |